Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the Diphtheria market grown in recent years?

Over the past few years, there has been a robust growth in the diphtheria market size. This market, which is currently valued at $8.91 billion in 2024, is forecasted to hit a value of $9.51 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.7%. The notable growth during the historical period is credited to developments in vaccines, immunization initiatives, heightened awareness, and advancements in healthcare infrastructure.

How is the diphtheria market size expected to evolve during the forecast period?

Predictions indicate a robust expansion in the diphtheria market over the forthcoming years, with a projected value of $12.35 billion by 2029, considering a compound annual growth rate (CAGR) of 6.8%. The speculated growth during the forecast period is attributed to factors like new outbreaks, booster vaccination drives, worldwide travel and migration, and public health readiness. The era also forecasts significant trends like integration of vaccines, utilization of telemedicine for vaccinations, initiatives for vaccine equality, and collaborations between public and private sectors.

Get your diphtheria market report here!

https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

Which key drivers are propelling the diphtheria market’s growth?

The diphtheria market is anticipated to experience significant growth due to the increasing incidences of bacterial infections. Bacterial infections occur when harmful bacteria invade the body and produce harmful toxins, leading to various diseases or conditions. One such serious infection is diphtheria, caused by bacteria strains that can weaken the immune system and enhance the growth of Corynebacterium diphtheria. For instance, NHS acute trusts in England reported 38,757 cases of E. coli bacteremia in the fiscal year 2022 to 2023, as shared by the GOV.UK website in September 2024. Of the total, 20.3% or 7,881 cases were recognized as hospital-onset infections. Hence, the surge in bacterial infections serves as a catalyst for the diphtheria market. Expanding Immunization Programs Propel the Diphtheria Market Forward

What are the market segments in the diphtheria industry?

The diphtheria market covered in this report is segmented –

1) By Type: Diphtheria, Skin Diphtheria, Other Types

2) By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis

3) By Treatment: Antibiotics, Antitoxin, Other Treatments

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Diphtheria: Respiratory Diphtheria, Non-respiratory Diphtheria

2) By Skin Diphtheria: Cutaneous Diphtheria

3) By Other Types: Diphtheritic Myocarditis, Diphtheritic Neuritis

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

Which leading companies are shaping the growth of the diphtheria market?

Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

What key trends are currently impacting the diphtheria market’s development?

Major industry players in the diphtheria market are focusing on the creation of innovative drugs and securing necessary approvals to maintain their market standing. For instance, GlaxoSmithKline PLC, a pharmaceutical and biotechnology firm based in the UK, revealed in October 2022 that it had received approval from the US Food and Drug Administration (FDA) for BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap). This vaccine is intended for immunization during the third month of pregnancy to help prevent pertussis (whooping cough) in infants under the age of two months. The highest level of protection against whooping cough during the initial months of a newborn’s life is provided through administering the Tdap vaccine during pregnancy. This process facilitates the transfer of protective antibodies from the mother to the child.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13016

Which geographic areas are influencing the growth of the diphtheria market?

Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

E-Pharmacy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Generic Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: